We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+8.17%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$124M
AUM Growth
+$2.88M
Cap. Flow
-$3.75M
Cap. Flow %
-3.02%
Top 10 Hldgs %
23.02%
Holding
579
New
33
Increased
147
Reduced
263
Closed
32

Top Sells

Rank Stock Value
1
TWTR
Twitter, Inc.
TWTR
+$2.59M
2
ECL icon
Ecolab
ECL
+$2.48M
3
TRIP icon
TripAdvisor
TRIP
+$2.39M
4
CPN
Calpine Corporation
CPN
+$2.37M
5
LAZ icon
Lazard
LAZ
+$2.34M

Sector Composition

Rank Sector Weight
1 Technology 19.51%
2 Industrials 16.14%
3 Healthcare 14.95%
4 Consumer Discretionary 13.43%
5 Consumer Staples 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFIV icon
26
F5
FFIV
$22.7B
$2M 1.61%
+15,362
New +$1.91M
ILMN icon
27
Illumina
ILMN
$28.4B
$1.99M 1.6%
+11,085
New +$1.95M
UTHR icon
28
United Therapeutics
UTHR
$23.1B
$1.98M 1.6%
15,306
+15,264
+36,343% +$1.97M
MNST icon
29
Monster Beverage
MNST
$88.5B
$1.97M 1.59%
+109,302
New +$1.89M
PCYC
30
DELISTED
PHARMACYCLICS INC
PCYC
$1.88M 1.51%
+15,379
New +$1.97M
TGT icon
31
Target
TGT
$68B
$985K 0.79%
12,975
-365
-3% -$24.6K
CSCO icon
32
Cisco
CSCO
$479B
$903K 0.73%
32,469
-731
-2% -$18.9K
ADM icon
33
Archer Daniels Midland
ADM
$36.9B
$887K 0.71%
17,064
+5,874
+52% +$293K
WEC icon
34
WEC Energy
WEC
$35.1B
$881K 0.71%
16,699
ADI icon
35
Analog Devices
ADI
$190B
$880K 0.71%
15,848
OHI icon
36
Omega Healthcare
OHI
$14.7B
$874K 0.7%
22,358
+385
+2% +$14.6K
LMT icon
37
Lockheed Martin
LMT
$136B
$868K 0.7%
4,510
-609
-12% -$113K
DFT
38
DELISTED
DuPont Fabros Technology Inc.
DFT
$860K 0.69%
+25,860
New +$803K
PAYX icon
39
Paychex
PAYX
$42.7B
$857K 0.69%
18,567
-567
-3% -$26.2K
BLK icon
40
Blackrock
BLK
$176B
$854K 0.69%
2,388
+43
+2% +$14.7K
ACH
41
Accendra Health
ACH
$214M
$851K 0.68%
24,252
-43
-0.2% -$1.45K
ABBV icon
42
AbbVie
ABBV
$435B
$848K 0.68%
12,961
-3,536
-21% -$223K
DLR icon
43
Digital Realty Trust
DLR
$71.7B
$841K 0.68%
12,685
LLY icon
44
Eli Lilly
LLY
$1.06T
$841K 0.68%
12,186
-288
-2% -$19.4K
CLX icon
45
Clorox
CLX
$12.7B
$840K 0.68%
8,064
+450
+6% +$45K
PG icon
46
Procter & Gamble
PG
$339B
$838K 0.67%
9,202
CINF icon
47
Cincinnati Financial
CINF
$27.1B
$834K 0.67%
16,097
-629
-4% -$31.5K
PNY
48
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$834K 0.67%
21,161
+1,321
+7% +$49.2K
GPC icon
49
Genuine Parts
GPC
$18.7B
$833K 0.67%
7,820
-774
-9% -$75.8K
WMT icon
50
Walmart Inc
WMT
$890B
$833K 0.67%
+29,094
New +$786K

Similar funds

Weaver C. Barksdale & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Weaver C. Barksdale & Associates held 579 positions worth $124M, up 2.4% from $121M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Weaver C. Barksdale & Associates withdrew a net $3.75M in Q4 2014, closing 32 positions and reducing 263 holdings. Its most notable exit was Twitter, Inc., an estimated $2.59M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Weaver C. Barksdale & Associates opened a new position in PHARMACYCLICS INC worth $1.88M.

  • Weaver C. Barksdale & Associates's largest Q4 2014 buy was PHARMACYCLICS INC: 15,379 shares worth $1.88M.
  • Weaver C. Barksdale & Associates added most to Service Corp International in Q4 2014, an estimated $1.97M increase.
  • Weaver C. Barksdale & Associates's biggest Q4 2014 reduction was B/E Aerospace Inc, cutting an estimated $2.23M.
  • Weaver C. Barksdale & Associates fully exited Twitter, Inc. in Q4 2014, selling an estimated $2.59M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 23% of its $124M portfolio in Q4 2014.
  • Weaver C. Barksdale & Associates opened 33 new positions and closed 32 in Q4 2014.
  • Weaver C. Barksdale & Associates's portfolio value rose 2.4% quarter-over-quarter to $124M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2014, filed 12 Jan 2015.